“Radiolabeled Peptide As Diagnostic, Therapeutic, and Theranostic Agents for Prostate Cancer: Systematic Literature Review”. Pharmaceutical Reports, vol. 1, no. 1, Mar. 2022, https://doi.org/10.33096/pharmrep.v1i1.174.